ANGION BIOMEDICA CORP (ANGN) Stock Income Statement
NASDAQ:ANGN • US03476J1079
Current stock price
1 USD
+0.02 (+2.04%)
At close:
0.9437 USD
-0.06 (-5.63%)
After Hours:
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 653.00K | 2.30M | 28.31M | 2.88M | 1.49M | |||
| Cost Of Goods | N/A | 0.00 | 433.00K | 1.19M | 640.00K | |||
| Gross Profit | N/A | 2.30M | 27.88M | 1.69M | 850.00K | |||
| Operating Expenses | 24.45M | 32.74M | 67.19M | 56.96M | 39.44M | |||
| Research and Development | 9.50M | 18.10M | 48.70M | 38.98M | 29.84M | |||
| Selling, General, and Administrative Expenses | 14.96M | 14.64M | 18.49M | 17.99M | 9.60M | |||
| Operating Income | -23.80M | -30.44M | -39.31M | -55.27M | -38.59M | |||
| Interest Income/Expense | 895.00K | 719.00K | -2.19M | -8.25M | 490.00K | |||
| Other Income/Expense | -256.00K | 95.00K | -13.98M | -16.53M | -2.56M | |||
| Non Recurring Items | N/A | -9.19M | 905.00K | N/A | N/A | |||
| Income Before Taxes | -29.10M | -38.81M | -54.57M | -80.11M | -40.66M | |||
| Net Income | -29.10M | -38.81M | -54.57M | -80.11M | -40.66M | |||
| EBITDA | -23.63M | -30.26M | -39.22M | -55.17M | -38.54M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.97 | -1.29 | -1.93 | -5.43 | -4.08 | |||
| Non GAAP EPS | N/A | -1.29 | -2.09 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 100.00% | 98.47% | 58.68% | 57.05% | |||
| Profit Margin | -4456.97% | -1686.53% | -192.76% | -2781.60% | -2728.86% | |||
| Operating Profit Margin | -3644.72% | -1322.73% | -138.84% | -1919.10% | -2589.93% | |||
All data in USD